EID * Volume 2 * Number 3 * July-September, 1996
Letters

Acute Cervical Lymphadenopathy


Download Article

To the Editor: Acute cervical lymphadenopathy has not been reported as a symptom of Mycobacterium genavense infection. In June 1994, a 32-year-old injecting drug user, who had been monitored since 1987 for human immunodeficiency virus (HIV) infection at the outpatient clinic of the Infectious Disease Institute, Perugia, Italy, was admitted to a hospital with fever (39°C) and progressive swelling over the submandibular region and neck. In addition to being febrile, upon physical examination the patient had tender left submandibular and cervical lymphadenopathy approximately 3 cm in diameter, with redness and edema of the overlying skin. The CD4+ lymphocyte count was 0.01 x 109/L. A specimen obtained by needle aspiration of the submandibular lymph node contained numerous acidfast bacilli, and the patient was treated with isoniazid, rifampin, ethambutol, and amikacin for presumed Mycobacterium tuberculosis with a good response; however, 10 days later, the patient's submandibular pain recurred along with abdominal pain and bowel irregularities. Gastroscopy showed superficial duodenal erosions, and acidfast bacilli were visualized by microscopy. Shortly thereafter, pain and swelling of the patient's right ankle developed, and small lesions were noted on the dorsum of the right foot. Clarithromycin was substituted for the amikacin for suspected without a clear response, and a course of steroids was initiated with clinical improvement. Symptoms recurred when the steroids wre tapered. Ciprofloxacin was substituted for isoniazid, and amikacin was readministered. Material from a repeat needle aspiration of the submandibular node 1 month later also showed acidfast bacilli by microscopy.

Cultures of the initial submandibular aspirate demonstrated poor growth in Bactec 13A broth and did not grow on solid media. The specimen was sent to a reference laboratory where acidfast bacilli were successfully isolated 10 weeks later in Middlebrook agar containing mycobactin J. These acidfast bacilli were subsequently identified as M. genavense by highpressure liquid chromatography and nucleic acid sequencing of the 16S rRNA. By this point, the patient had improved on a regimen of isoniazid, pyrazinamide, clofazimine, and amikacin for presumed M. genavense infection, and this regimen was continued. The patient died 19 months later; cultures for mycobacteria were persistently negative even when antimycobacterial drugs were discontinued 16 months after the initial episode.

M. genavense is a novel mycobacterial species that causes serious disseminated infections with massive involvement of the small intestine, spleen, liver, and abdominal lymph nodes in profoundly immunocompromised persons. Cultures with Bactec 13A vials containing radiometric liquid medium are generally positive but subcultures on solid media are unsuccessful (1). Lowering the pH of medium to six enhances its growth (1), while adding mycobactin J to Middlebrook 7H11 (2) solid media can help in the isolation. The suppression of growth of M. genavense by NAP can cause confusion with the M. tuberculosis complex; however, M. genavense can be easily distinguished by its slow growth and its dysgonic nature. At present, the way to identify M. genavense is by 16S rRNA sequencing (3). Highpressure liquid chromatography can be used (4).

Maria Bruna Pasticci, M.D.,* F. Baldelli,* F. Bistoni, C. Piersimoni, G. Sbaraglia, G. Stagni, and S. Pauluzzi

*Infectious Disease Institute, Perugia University, Policlinico Monteluce, Perugia, Italy; Department of Experimental Medicine and Biochemical Sciences, Microbiology Section, Perugia University, Perugia, Italy; and Department of Clinical Microbiology, “Umberto I Torrette” Hospital, Ancona, Italy

References

  1. Tortoli E, Simonetti MT, Dionisio D, Meli M. Cultural studies on two isolates of Mycobacterium genavense from patients with acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis 1994; 18:7-12.
  2. Kiehn TE. The diagnostic mycobacteriology laboratory of the 1990s. Clin Infect Dis 1993; 17(Suppl 2):S447-454.
  3. Kirshner P, Springer B, Meier A, Wrede A, Kiekenbeck M, Bange FC. Genotypic identification of mycobacteria by nucleic aid sequence determination—report of a 2-year experience in a clinical laboratory 1993; J Clin Microbiol; 31:2882-9.
  4. Toroli E, Bartoloni A, Burrini C, Mantella A, Simonetti MT. Utility of high-performance liquid chromatography for identification of mycobacterial species rarely encountered in clinical laboratories. Eur J Clin Microbiol Infect Dis 1995; 14:240-3.

AIDS: Déjà Vu in Ancient Egypt?

To the Editor: The recent letter by Olson et al. (1) on the plague of Athens and the “reemergence (?)” of Ebola virus prompts brief reiteration of an earlier communication (2) placing human immunodeficiency virus (HIV) back in history, possibly in the time of the pharaohs.

Translations of the Papyrus Ebers from ancient Egyptian literature repeatedly make reference to difficulties in the diagnosis of conditions under the names AAA disease, uxedu-disease, and uha-disease (3). The interpretation of these diseases has been inconclusive among Egyptologists. However, the many remedies proposed for the ravages of AAA, whether by itself or complicated by uxedu- or uha-disease, brand it as a scourge of first magnitude. AAA is mentioned 50 times in four papyri (28 times in Papyrus Ebers, 12 times in Papyrus Berlin, 9 times in Papyrus Hearst, and once in the London Papyrus [4]). The hieroglyphic symbol for AAA (5) is shown below.

figure
The hieroglyphic symbol for AAA disease, translated as "semen" or "poison" (From: Von Deines and Westeneorf [5]).

Could this be documentation of HIV, or more accurately its prototype, occurring in Egypt during the time of the pharaohs?

Richard J. Ablin, Ph.D.
Innapharma, Inc.
Suffern, New York, USA

References

  1. Olson PE, Hames CS, Benenson AS, Genovese EN. The Thucydides syndrome: Ebola déjà vu? (or Ebola reemergent?). Emerging Infectious Diseases 1996;2:1556.
  2. Ablin RJ, Immerman RS, Gonder MJ. AIDS: a disease of ancient Egypt? NY State J Med 1985;85:2001.
  3. Bryan CP, Smith GE. The , In: Ancient Egyptian medicine: the Papyrus Ebers. Chicago: Ares Publishers, 1924:11923.
  4. Ghalioungui P. Magic and medical science in ancient Egypt. London, UK: Hodder and Stoughton, 1963.
  5. Von Deines H, Westeneorf W. Wöterbuch der medizimischen texte. Berlin, Germany: AkademieVerlag, 1961;7,Part 1:129.


Table of Contents

Updated: Thursday, July 25, 1996